Israel News
Most Popular Israel Story
ALSO NOTED: Zingo data lifts Anesiva stock; Two chemo drugs win approvals; BrainStorm plans trials; and much more...
> Shares of Anesiva jumped after the company announced positive top-line data from a late-stage study of Zingo, its drug candidate for reducing venous procedural pain. Read more...
Latest Headlines
- August 29, 2008
- August 21, 2008
- June 26, 2008
- April 8, 2008
- April 1, 2008
- December 5, 2007
- August 13, 2007
- December 10, 2006
- October 29, 2006
- October 4, 2006
- September 26, 2006
- September 6, 2006
- August 21, 2006
- July 17, 2006
- July 11, 2006
- May 22, 2006
- May 17, 2006
- May 14, 2006
Paid Research Reports
- RNA therapy: the next big thing after monoclonal antibodies?
- Biotech M&A Strategies: Deal assessments, trends and future prospects
- The Dermatology Market Outlook to 2013: Competitive landscape, pipeline analysis and growth opportunities
- Pipeline Insight: Cancer Overview - Breast, Gynecological, Genitourinary - Diverse drugs approaching the market for many tumor t
- Sales Force Effectiveness
